Ocean Biomedical receives Nasdaq delisting affirmation; shares to be suspended

Ocean Biomedical, Inc.

Listing Council affirms Nasdaq's decision to delist Ocean Biomedical securities, effective April 24, 2025.
Company had appealed the Panel's April 22, 2025 delisting decision, but the appeal was denied.
Trading suspension to begin at opening of business on April 24, 2025.

item 3.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.